Usefulness of OPC-8212, a quinolinone derivative, for chronic congestive heart failure in patients with ischemic heart disease or idiopathic dilated cardiomyopathy
- 1 November 1991
- journal article
- clinical trial
- Published by Elsevier BV in The American Journal of Cardiology
- Vol. 68 (11), 1203-1210
- https://doi.org/10.1016/0002-9149(91)90194-p
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- A placebo-controlled, randomized, double-blind study of OPC-8212 in patients with mild chronic heart failureCardiovascular Drugs and Therapy, 1990
- A Comparison of Oral Milrinone, Digoxin, and Their Combination in the Treatment of Patients with Chronic Heart FailureNew England Journal of Medicine, 1989
- Evaluation of a new inotropic agent, OPC-8212, in patients with dilated cardiomyopathy and heart failureAmerican Heart Journal, 1988
- Analysis of Recurrent Events: Nonparametric Methods for Random-Interval Count DataJournal of the American Statistical Association, 1988
- DigitalisNew England Journal of Medicine, 1988
- Effects of Enalapril on Mortality in Severe Congestive Heart FailureNew England Journal of Medicine, 1987
- Acute hemodynamic effects of a new inotropic agent, OPC-8212, on severe congestive heart failureHeart and Vessels, 1986
- Acute Hemodynamic Effects of a New Positive Inotropic Agent, 3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2(1H)-quinolinone (OPC-8212), in Conscious and Anesthetized DogsJournal of Cardiovascular Pharmacology, 1986
- Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.Cell Metabolism, 1985
- Two-Sample Asymptotically Distribution-Free Tests for Incomplete Multivariate ObservationsJournal of the American Statistical Association, 1984